Canada markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2240-0.0160 (-6.67%)
At close: 04:00PM EDT
0.2340 +0.01 (+4.46%)
After hours: 07:48PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 11.17M
Enterprise Value 7.17M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.34
Price/Book (mrq)1.78
Enterprise Value/Revenue 0.85
Enterprise Value/EBITDA -0.11

Trading Information

Stock Price History

Beta (5Y Monthly) 1.13
52-Week Change 3-97.11%
S&P500 52-Week Change 3-10.33%
52 Week High 311.1200
52 Week Low 30.1750
50-Day Moving Average 30.2511
200-Day Moving Average 30.3832

Share Statistics

Avg Vol (3 month) 3758.03k
Avg Vol (10 day) 31.15M
Shares Outstanding 546.54M
Implied Shares Outstanding 6N/A
Float 846.45M
% Held by Insiders 10.16%
% Held by Institutions 13.54%
Shares Short (Mar 14, 2023) 4225.72k
Short Ratio (Mar 14, 2023) 40.57
Short % of Float (Mar 14, 2023) 40.49%
Short % of Shares Outstanding (Mar 14, 2023) 40.48%
Shares Short (prior month Feb 14, 2023) 4524.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Apr 26, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Dec 30, 2022


Profit Margin -233.48%
Operating Margin (ttm)-380.69%

Management Effectiveness

Return on Assets (ttm)-96.67%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)10.88M
Revenue Per Share (ttm)0.50
Quarterly Revenue Growth (yoy)163.90%
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-25.41M
Diluted EPS (ttm)-1.2000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.25M
Total Cash Per Share (mrq)0.11
Total Debt (mrq)2.21M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.85
Book Value Per Share (mrq)-0.13

Cash Flow Statement

Operating Cash Flow (ttm)-35.95M
Levered Free Cash Flow (ttm)-23.95M